PMC:7555630 / 9809-10320
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T11 | 274-280 | Body_part | denotes | mental | http://purl.org/sig/ont/fma/fma264279 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T90 | 176-184 | Disease | denotes | dementia | http://purl.obolibrary.org/obo/MONDO_0001627 |
| T91 | 502-510 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T43 | 291-292 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T44 | 338-339 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T13 | 356-365 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T14 | 378-396 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
| T15 | 398-409 | Chemical | denotes | oseltamivir | http://purl.obolibrary.org/obo/CHEBI_7798 |
| T16 | 411-421 | Chemical | denotes | amantadine | http://purl.obolibrary.org/obo/CHEBI_2618 |
| T17 | 427-436 | Chemical | denotes | memantine | http://purl.obolibrary.org/obo/CHEBI_64312 |
| T18 | 470-480 | Chemical | denotes | adamantane | http://purl.obolibrary.org/obo/CHEBI_40519 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T65 | 88-100 | Phenotype | denotes | parkinsonism | http://purl.obolibrary.org/obo/HP_0001300 |
| T66 | 176-184 | Phenotype | denotes | dementia | http://purl.obolibrary.org/obo/HP_0000726 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T67 | 0-511 | Sentence | denotes | Of the patients who died, twelve (92%) were greater than 60 years old, eleven (85%) had parkinsonism, eleven (85%) were from an extended care facility, nine (69%) had comorbid dementia, nine (69%) had at least one high-risk comorbid condition, eight (62%) had alteration in mental status as a presenting symptom, and eight (62%) received a medication with antiviral properties (hydroxychloroquine, oseltamivir, amantadine, and memantine), including three who were on an adamantane prior to contracting COVID-19. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 323 | 7-15 | Species | denotes | patients | Tax:9606 |
| 326 | 20-24 | Disease | denotes | died | MESH:D003643 |
| 327 | 88-100 | Disease | denotes | parkinsonism | MESH:D010302 |
| 328 | 176-184 | Disease | denotes | dementia | MESH:D003704 |
| 329 | 502-510 | Disease | denotes | COVID-19 | MESH:C000657245 |